Board meeting on Nov 2 to consider Q2 and H1 FY26 results

Results View source PDF Explain this filing

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.1%Reaction day

₹5570.00

prior close

₹5515.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-2.8% vs market

Pharmaceuticals peers, median of 173sector-0.8%-3.3% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.5

15m

-0.3

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.1-1.3-2.8-0.8-3.3

Next day

-4.8-1.3-3.6-1.2-3.6

-4.8+0.0-4.9-0.4-4.4

-5.9-0.2-5.7-0.1-5.8

-7.1-3.0-4.2-3.0-4.1

-6.0-2.7-3.3-3.1-2.9

-4.4-1.7-2.6-3.0-1.3

15d

-8.5-8.9+0.4-6.9-1.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Procter and Gamble Health has informed the stock exchanges that its Board of Directors will meet on Monday, November 2, 2026 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026. The intimation is filed under SEBI listing regulations. No financial figures or other agenda items are disclosed in this filing.

Likely market impact

Investors should await the Q2 and H1 FY26 results on or after November 2, 2026 for updated financial performance data.